Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice

Cancer Research

Volumn 57, Issue 14, 1997, Pages 3016-3025

  Auvinen, Merja ^a,c   Laine, Aire ^b   Paasinen Sohns, Aino ^a   Kangas, Anneli ^a   Kangas, Lauri ^b   Saksela, Olli ^a   Andersson, Leif C ^a   Hölttä, Erkki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b ORION CORPORATION   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ORNITHINE DECARBOXYLASE; POLYAMINE; THROMBOSPONDIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL STRAIN 3T3; EMBRYO; FIBROSARCOMA; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RAT; TUMOR GROWTH; TUMOR VASCULARIZATION; VASCULAR TUMOR;

3T3 CELLS; ANIMALS; CATTLE; CELL TRANSFORMATION, NEOPLASTIC; ENDOTHELIAL GROWTH FACTORS; GENES, JUN; GENES, MYC; GENES, P53; HUMANS; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; ORNITHINE DECARBOXYLASE; RNA, MESSENGER; THROMBOSPONDINS; URINARY PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030834335     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. Tabor, C. W., and Tabor, H. Polyamines. Annu. Rev. Biochem., 53: 749-790, 1984.
2. Pegg, A. Polyamine metabolism and its importance in neoplastic cell growth and as target for chemotherapy. Cancer Res., 48: 759-774, 1988.
3. Jänne, J., Alhonen, L., and Leinonen, P. Polyamines: from molecular biology to clinical applications. Ann. Med., 23: 241-259, 1991.
4. Pegg, A., Shantz, L., and Coleman, C. Ornithine decarboxylase as a target for chemoprevention. J. Cell. Biochem., 22 (Suppl.): 132-138, 1995.
5. v-src: delineation of molecular events relevant for the transformed phenotype. J. Cell Biol., 122: 903-914, 1993.
6. Sistonen, L., Hölttä, E., Lehväslaiho, H., Lehtola, L., and Alitalo, K. Activation of chimeric EGF-R/neu tyrosine kinase induces the fos/jun transcription factor complex, glucose transporter, and ornithine decarboxylase. J. Cell Biol., 109: 1911-1919, 1989.
7. Hölttä, E., Sistonen, L., and Alitalo, K. The mechanism of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH3T3 cells. J. Biol. Chem., 263: 4500-4507, 1988.
8. Auvinen, M., Paasinen, A., Andersson, L. C., and Hölttä, E. Ornithine decarboxylase activity is critical for cell transformation. Nature (Lond.), 360: 355-358, 1992.
9. Moshier, J., Dosescu, J., Skunca, M., and Luk, G. Transformation of NIH3T3 cells by ornithine decarboxylase overexpression. Cancer Res., 53: 2618-2622, 1993.
10. Shantz, L., and Pegg, A. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res., 54: 2313-2316, 1994.
11. Clifford, A., Morgan, D., Yuspa, S., Soler, A., and Gilmour, S. Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res., 55: 1680-1686, 1995.
12. Megosh, L., Gilmour, S., Rosson, D., Soler, A., Blessing, M., Sawicki, J., and O'Brien, T. Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Res., 55: 4205-4209, 1995.
13. Bello-Fernandez, C., Packham, G., and Cleveland, J. The ornithine decarboxylase is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA, 90: 7804-7808, 1993.
14. Wrighton, C., and Busslinger, M. Direct transcriptional stimulation of the ornithine decarboxylase gene by Fos in PC12 but not in fibroblasts. Mol. Cell. Biol., 13: 4657-4669, 1993.
15. Folkman, J., and Shing, Y. Angiogenesis, J. Biol. Chem., 267: 10931-10934, 1992.
16. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
17. Fidler, I., and Ellis, L. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79: 185-188, 1994.
18. Hyvönen, T., Keinänen, T., Khomutov, A., Khomutov, R., and Eloranta, T. Monitoring the uptake and metabolism of amini analogues of polyamines in cultured cells by high performance liquid chromatography. J. Chromatogr., 574: 17-21, 1992.
19. Sambrook, J., Fritch, E., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2, chapter 7. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
20. Hickok, N., Seppänen, P., Gunsalus, P., and Jänne, O. A. Complete amino acid sequence of human ornithine decarboxylase deduced from complementary DNA. DNA (NY), 6: 179-187, 1987.
21. Hickok, N., Seppänen, P., Kontula, P., Jänne, P., Bardin, C., and Jänne, O. A. Two ornithine decarboxylase mRNA species in mouse kidney arise from size heterogeneity at their 3′termini. Proc. Natl. Acad. Sci. USA, 81: 594-598, 1986.
22. Pajunen, A., Crozat, A., Jänne, O. A. Ihalainen, R., Laitinen, P., Stanley, B., Madhubala, R., and Pegg, A. Structure and regulation of mammalian S-adenosylmethionine decarboxylase. J. Biol. Chem., 263: 17040-17049, 1988.
23. Matsufuji, S., Miyazaki, Y., Kanamoto, R., Kameji, T., Murakami, Y., Baby, T., Fujota, K., Ohno, T., and Hayashi, S. I. Analyses of ornithine decarboxylase antizyme mRNA with cDNA cloned from rat liver. J. Biochem., 108: 365-371, 1990.
24. Koskinen, P., Sistonen, L., Evan, G., Morimoto, R., and Alitalo, K. Nuclear colocolization of cellular and viral Myc proteins with HSP70 in Myc-overexpressing cells. J. Virol., 65: 842-851, 1991.
25. Mäkelä, T., Koskinen, P., Västrik, I., and Alitalo, K. Alternative forms of Max can act either as enhancers or suppressors of cotransformation by c-Myc and Ras. Science (Washington DC), 256: 373-377, 1992.
26. Ayer, D., Kretzner, L., and Eisenman, R. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell, 72: 211-222, 1993.
27. Sassone-Corsi, P., Lamph, W., Kamps, M., and Verma, I. fos-associated cellular p39 is related to nuclear transcription factor AP-1. Cell, 54: 553-560, 1988.
28. Ryder, K., Lau, L., and Nathans, D. A gene activated by growth factors is related to the oncogene v-jun. Proc. Natl. Acad. Sci. USA, 85: 1487-1491, 1988.
29. Eliahy, D., Michalowitz, D., Eliahy, S., Pinhasi-Kimhi, O., and Oren, M. Wild-type p53 can inhibit oncogene-mediated focus formation. Proc. Natl. Acad. Sci. USA, 86: 8763-8767, 1989.
30. Jaye, M., Howk, R., Burgess, W., Ricca, C., Chiu, I., Ravera, M., O'Brien, S., Modi, W., Maciag, T., and Drohan, W. Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. Science (Washington DC), 233: 541-545, 1986.
31. Sommer, A., Brewer, M., Thompson, R., Moscatelli, D., Presta, M., and Rifkin, D. A form of human basic fibroblast growth factor with an extended amino terminus. Biochem. Biophys. Res. Commun., 144: 543-550, 1987.
32. Delli-Bovi, P., and Basilico, C. Isolation of a rearranged human transforming gene following transfection of Kaposi's sarcoma DNA. Proc. Natl. Acad. Sci. USA, 84: 5660-5664, 1987.
33. Leung, D., Cachianes, G., Kuang, W-J., Goeddel, D., and Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Washington DC), 246: 1306-1309, 1989.
34. Murray, J., Buetow, K., and Bell, G. RFLPs for transforming growth factor α (TGFA) gene at 2p13. Nucleic Acids Res., 14: 7126-7131, 1986.
35. Derynck, R., Jarret, J., Chen, E., Eaton, D., Bell, J., Assoian, R., Roberts, A., Sporn, M., and Goeddel, D. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature (Lond.), 316: 701-705, 1985.
36. Leibovich, S., Polverini, P., Shepard, H., Wiseman, D., Shively, V., and Nuseir, N. Macrophage-induced angiogenesis is mediated by tumor necrosis factor-α. Nature (Lond.), 329: 630-632, 1987.
37. Mercola, M., Wang, C., Kelly, J., Brownlee, C., Jackson-Grusby, L., Stiles, C., and Bowen-Pope, D. Selective expression of PDGF A and its receptor during early mouse embryogenesis. Dev. Biol., 138: 114-122, 1990.
38. Maglione, D., Guerriero, V., Viglietto, G., Delli-Bovi, P., and Persico, G. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. USA, 88: 9267-9271, 1991.
39. Montesano, R., Matsumoto, K., Nakamura, T., and Orci, L. Identification of a fibroblast-derived epithelial morphogen as a hepatocyte growth factor. Cell, 67: 901-908, 1991.
40. Laherty, C., O'Rourke, K., Wolf, F., Katz, R., Seldin, M., and Dixit, V. Characterization of mouse thrombospondin 2 sequence and expression during cell growth and development. J. Biol. Chem., 267: 3274-3281, 1992.
41. Ruta, M., Burgess, W., Ricca, G., Drohan, W., Zabelhansky, M., Laureys, G., Barton, D., Francke, U., Schlessinger, J., and Givol, D. A novel protein tyrosine kinase gene whose expression is modulated during endothelial cell differentiation. Oncogene, 3: 9-15, 1988.
42. Dionne, C., Crumley, G., Bellot, F., Kaplow, J., Searforss, G., Ruta, M., Burgess, W., Jaye, M., and Schlessinger, J. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J., 9: 2685-2692, 1990.
43. Partanen, J., Mäkelä, T., Eerola, E., Korhonen, J., Hirvonen, H., Claesson-Welsh, L., and Alitalo, K. FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J., 10: 1347-1354, 1991.
44. Shibuya, M., Yamagachi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., and Sato, M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (flt) related to the fms family. Oncogene, 5: 519-524, 1990.
45. Terman, B., Dougher-Vermazen, M., Carrion, E., Dimitrov, D., Armellino, D., Gospodarowitch, D., and Böhlen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun., 187: 1579-1586, 1992.
46. Goldberg, G., Wilhelm, S., Kronberger, A., Bauer, E., Grant, G., and Eisen, A. Complete primary structure and homology to an oncogene transformation-induced rat protein. J. Biol. Chem., 261: 6600-6605, 1986.
47. Huhtala, P., Tuuttila, A., Chow, L., Lohi, J., Keski-Oja, J., and Tryggvason, K. Complete structure of human gene for 92-kDa type IV collagenase: divergent regulation of expression for the 92-kDa and 72-kDa enzyme genes in HT-1080 cells. J. Biol. Chem., 266: 16485-16490, 1991.
48. Collier, I., Wilhelm, S., Eisen, A., Maremer, B., Grant, G., Selzer, J., Kronberger, A., He, C., Bauer, E., and Goldberg, G. H-ras oncogene transformed human bronchial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J. Biol. Chem., 263: 6600-6605, 1988.
49. Basset, P., Bellocq, J. P., Wolf, C., Stoll, I., Hutin, P., Limacher, J. M., Podhajcer, O. L., Chenard, M. P., Rio, M. C., and Chambon, P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature, 348: 699-704, 1990.
50. Belin, D., Vassalli, J-D., Combepine, C., Godeau, F., Nagamine, Y., Reich, E., Kocher, H., and Duvoisin, R. Cloning, nucleotide sequencing and expression of cDNA encoding mouse urokinase-type plasminogen activator. Eur. J. Biochem., 148: 225-232, 1985.
51. Lohi, J., Lehti, K., Westermarck, J., Kähäri, V-M., and Keski-Oja, J. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur. J. Biochem., 219: 239-247, 1996.
52. Deutzman, R., Huber, J., Schmetz, K., Oberbäumer, I., and Hartl, L. Structural study of long arm fragments of laminin: evidence for repetitive C-terminal sequences in the A-chain, not present in the B-chain. Eur. J. Biochem., 177: 35-45, 1988.
53. Obermäuer, I. New pUC-derived expression vectors for rapid construction of cDNA libraries. Gene (Amst.), 49: 81-91, 1986.
54. CAS. Mol. Cell. Biol., 15: 6513-6525, 1995.
55. Alanko, T., Tienari, J., Lehtonen, E., and Saksela, O. FGF-2 inhibits apoptosis in human teratocarcinoma cells during differentiation on collagen substratum. Exp. Cell Res., 228: 306-312.
56. Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., and Alitalo, K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGF-R3) and KDR (VEGF-R2) receptor tyrosine kinases. EMBO J., 15: 101-110, 1996.
57. Celano, P., Baylin, S., and Casero, R. Polyamines differentially modulate the transcription of growth-associated genes in human colon carcinoma. J. Biol. Chem., 264: 8922-8927, 1989.
58. Tabib, A., and Bachrach, U. Activation of the proto-oncogene c-myc and c-fos by c-ras: involvement of polyamines. Biochem. Biophys. Res. Commun., 202: 720-727, 1994.
59. Packham, G., and Cleveland, J. Ornithine decarboxylase is a mediator of c-Myc induced apoptosis. Mol. Cell. Biol., 14: 5741-5747, 1994.
60. Poulin, R., Pelletier, G., and Pegg, A. Induction of apoptosis by excessive polyamine accumulation in ornithine decarboxylase overproducing LI210 cells. Biochem. J., 34: 723-727, 1995.
61. Weinberg, R. A. Tumor suppressor genes. Science (Washington DC), 254: 1138-1146, 1991.
62. Levine, A. J. The tumor suppressor genes. Annu. Rev. Biochem., 62: 623-651, 1993.
63. Ullrich, A., and Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell, 61: 203-212, 1990.
64. Moshier, J., Malecka-Panas, E., Geng, H., Dosescu, J., Tureaud, J., Skunca, M., and Majumdar, A. Ornithine decarboxylase transformation of NIH3T3 cells is mediated by altered growth factor receptor activity. Cancer Res., 55: 5358-5365, 1995.
65. Sakai, R., Iwamatsu, A., Hirano, N., Ogawa, S., Tanaka, T., Mano, H., Yazaki, Y., and Hirai, H. A novel signaling molecule, p130, forms stable complexes in vivo with c-Crk and v-Src in a tyrosine-phosphorylation-dependent manner. EMBO J., 13: 3748-3756, 1994.
66. Sappino, A., Busso, N., Belin, D., and Vassali, J. Increase of urokinase type plasminogen activator gene expression in human lung and breast carcinomas. Cancer Res., 47: 4043-4046, 1987.
67. Stetler-Stevenson, W., Axnavoorian, S., and Liotta, E. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol., 9: 541-573, 1993.
68. Sato, H., Takino, T., Okada, Y., Shinagawa, A., Yamamoto, E., and Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (Lond.), 370: 61-65, 1994.
69. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
70. Yurchenco, P., and O'Rear, J. Basal lamina assembly. Curr. Biol., 6: 674-681, 1994.
71. Folkman, J., Watson, K., Ingber, D., and Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (Lond.), 339: 58-61, 1989.
72. Nabel, E., Yang, Z-Y., Plautz, G., Forough, R., Zhan, X., Haudenschild, C., Maciag, T., and Nabel, G. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature (Lond.), 362: 844-846, 1993.
73. Kim, J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (Lond.), 362: 841-844, 1993.
74. Klagsbrun, M., and Soker, S. VEGF/VPF: the angiogenesis factor found? Curr. Biol., 3: 699-701, 1993.
75. Schweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
76. Plate, K., Breier, G., Weich, H., and Risau, W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
77. Vries, C., Escobedo, J., Ueno, H., Houck, Ferrara, N., and Williams, L. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (Washington DC), 255: 989-991, 1992.
78. Millauer, B., Wizigman-Voos, S., Schnurch, H., Martinez, R., Moller, N., Risau, W., and Ullrich, A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72: 835-846, 1993.
79. Symonds, H., Krall, L., Remington, L., Saenz-Robles, Lowe, S., Jacks, T., and Van Dyke, T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78: 703-711, 1994.
80. Graeber, T., Osmanian, C. Jacks, T., Housman, D., Koch, C., Lowe, S., and Giaccia, A. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature (Lond.), 379: 88-91, 1996.
81. Rastinejad, F., Polverini, P., and Bouck, N. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell, 56: 345-355, 1989.
82. Good, D., Polverini, P., Rastinejad, F., Le Beau, M., Lemons, R., Frazier, W., and Bouck, N. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistiguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA, 87: 6624-6628, 1990.
83. Dameron, K., Volpert, O., Tainsky, M., and Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science (Washington DC), 265: 1582-1584, 1994.
84. Takigawa, M., Enomoto, M., Nishida, Y., Pan, H-O., Kinoshota, A., and Suzuki, F. Polyamines and angiogenesis: inhibition of tumor angiogenesis by the irreversible inhibitor of ornithine decarboxylase, α-difluoromethylornithine. In: S. H. Goldemberg and I. D. Algranati (eds.), The biology and Chemistry of Polyamines, pp. 203-211. Oxford, United Kingdom: IRL Press, 1990.
85. Sunkara, P., and Rosenberger, A. Antimetastatic activity of DL-α-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice. Cancer Res., 47: 933-935, 1987.